The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...

In a major policy shift, federal health officials anticipate the shots will be made available to adults 65 and older as well ...

The Trump administration announced Tuesday that going forward, COVID-19 vaccines would be FDA-approved only for people over ...

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans. The agency is changing ...

The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.

The Food and Drug Administration has outlined new regulations for COVID-19 booster shots, setting stricter approval standards ...

After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...

The US Food and Drug Administration (FDA) announced today that it will only recommend COVID-19 vaccines for adults 65 and ...

Vaccine makers are required to run fresh clinical trials before offering shots to younger and healthier individuals. Read ...

Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 vaccine ...

"Here is a prime example of just how influential Big Pharma still is," MAHA influencer Diana Atieh told Newsweek.

The FDA's decision involves changing the standard of evidence required for COVID-19 vaccine approval in the U.S.